Attached files

file filename
EX-32.2 - EXHIBIT 32.2 - BIO-RAD LABORATORIES, INC.ex322123116.htm
EX-32.1 - EXHIBIT 32.1 - BIO-RAD LABORATORIES, INC.ex321123116.htm
EX-31.2 - EXHIBIT 31.2 - BIO-RAD LABORATORIES, INC.ex312123116.htm
EX-31.1 - EXHIBIT 31.1 - BIO-RAD LABORATORIES, INC.ex311123116.htm
EX-21.1 - EXHIBIT 21.1 - BIO-RAD LABORATORIES, INC.ex211123116.htm
10-K - 10-K 2016 - BIO-RAD LABORATORIES, INC.a10k123116.htm


Exhibit 23.1




Consent of Independent Registered Public Accounting Firm




The Board of Directors
Bio-Rad Laboratories, Inc.

We consent to the incorporation by reference in the registration statement on Form S-3 (No. 333‑170981) and on Forms S-8 (Nos. 333-144962, 333-133507, 333-124187, 333-53335, 333-53337, 333-179876, 333-197979 and 333-206885) of Bio-Rad Laboratories, Inc. of our reports dated February 28, 2017, with respect to the consolidated balance sheets of Bio-Rad Laboratories, Inc. and subsidiaries (the Company) as of December 31, 2016 and 2015, and the related consolidated statements of income, comprehensive income, stockholders’ equity, and cash flows for each of the years in the three-year period ended December 31, 2016, and financial statement schedule, and the effectiveness of internal control over financial reporting as of December 31, 2016, which reports appear in the December 31, 2016 annual report on Form 10‑K of Bio-Rad Laboratories, Inc.

                            /s/ KPMG LLP
San Francisco, California
February 28, 2017